EUVIMEDEUVIMED entdecken
Crossref

Dihydroxyacetone phosphate is a novel predictor of hepatic fibrosis in Latino adolescents with obesity

Rachel B Schenker iD, Cuauhtemoc B Ramirez, Cholsoon Jang, Hooman Allayee, Xueheng Zhao, Kenneth D R Setchell, Rohit Kohli, Michael I Goran

Journal of Pediatric Gastroenterology and Nutrition · 2025

DOI: 10.1002/jpn3.12420 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pediatric Gastroenterology and Nutrition, 2025. Verfasst von Rachel B Schenker und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Children's Hospital Los Angeles, Los Angeles, California, USA. Hauptthemen laut MEDLINE: Biomarkers, Elasticity Imaging Techniques, Hispanic or Latino, Liver Cirrhosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: NIH HHS, Interdisciplinary Cancer Research Program, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Metabolic dysfunction‐associated steatotic liver disease (MASLD) is the most common pediatric liver disease and can progress to liver fibrosis. Latino adolescents have increased MASLD and fibrosis risk. While fibrosis is diagnosed by biopsy or imaging, more accessible, noninvasive, and economical screening methods are needed. We aimed to use plasma metabolomics/lipidomics to identify potential fibrosis biomarkers in Latino adolescents with obesity.

Methods

Liver stiffness (LS) was measured in 93 Latino adolescents with obesity using magnetic resonance elastography. Metabolites and lipids were extracted from plasma and identified on Compound Discoverer. Associations between metabolites/lipids and fibrosis (LS > 2.73 kPa) were determined using linear regression models after covariate adjustment. False discovery rate (FDR) adjusted Pearson's correlations were performed. Analytes yielding significant FDR‐adjusted correlations were examined further by receiver operator curve analysis.

Results

Mean (±standard deviation) alanine transaminase (ALT) was 45.7(±65.2) IU/L, hepatic fat fraction was 12.7(±9.1)%, and LS was 2.4(±0.3) kPa. We identified 795 metabolites and 413 lipids in plasma, but only one single metabolite, dihydroxyacetone phosphate (DHAP), a marker of triglyceride synthesis, was significantly associated with fibrosis after FDR adjustment ( p < 0.05). In terms of predicting fibrosis, ALT had an area under the curve (AUC) of 0.79, and DHAP had an AUC of 0.79. When combined, ALT + DHAP had an AUC of 0.89.

Conclusions

The combination of ALT + DHAP may have the potential as an accurate, noninvasive test for liver fibrosis. Our data are limited to Latino children with obesity, and a larger cohort should be examined to further validate this novel biomarker.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiomarkersElasticity Imaging TechniquesHispanic or LatinoLiver CirrhosisPediatric ObesityAdolescentChildFemaleHumansMaleLipidomicsLiverMetabolomicsPredictive Value of Tests

Stichwörter der Autor:innen

MASLDNAFLDlipidomicsmetabolic dysfunction‐associated steatotic liver diseasemetabolomics

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Children's Hospital Los Angeles, Los Angeles, California, USA.
  • Department of Biologic Chemistry, University of California Irvine School of Medicine, Irvine, California, USA.
  • Departments of Population & Public Health Sciences and Biochemistry & Molecular Medicine, University of Southern California, Los Angeles, California, USA.
  • Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
  • Cincinnati Children's Hospital Medical Center, Division of Pathology and Laboratory Medicine, Cincinnati, Ohio, USA.
  • Department of Pediatrics, Division of Endocrinology, Children's Hospital Los Angeles, Los Angeles, California, USA.

ORCID-Profile: Rachel B Schenker

Förderung

  • NIH HHS
  • Interdisciplinary Cancer Research Program
  • NIDDK NIH HHS
  • NCI NIH HHS

Zitieren

APA

Schenker, R. B., Ramirez, C. B., Jang, C., Allayee, H., Zhao, X., Setchell, K. D. R., Kohli, R., & Goran, M. I. (2025). Dihydroxyacetone phosphate is a novel predictor of hepatic fibrosis in Latino adolescents with obesity. Journal of Pediatric Gastroenterology and Nutrition. https://doi.org/10.1002/jpn3.12420

Vancouver

Schenker RB, Ramirez CB, Jang C, Allayee H, Zhao X, Setchell KDR, et al. Dihydroxyacetone phosphate is a novel predictor of hepatic fibrosis in Latino adolescents with obesity. Journal of Pediatric Gastroenterology and Nutrition. 2025. doi:10.1002/jpn3.12420

BibTeX
@article{Schenker2025,
  author = {Schenker, Rachel B and Ramirez, Cuauhtemoc B and Jang, Cholsoon and Allayee, Hooman and Zhao, Xueheng and Setchell, Kenneth D R and Kohli, Rohit and Goran, Michael I},
  title = {Dihydroxyacetone phosphate is a novel predictor of hepatic fibrosis in Latino adolescents with obesity},
  journal = {Journal of Pediatric Gastroenterology and Nutrition},
  year = {2025},
  doi = {10.1002/jpn3.12420}
}
Kostenlos starten →